Case number 1:22-cv-01348
Merck Sharp & Dohme LLC v. Laurus Labs Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Dec 30, 2022 | 8 | CONSENT JUDGMENT between Plaintiff and "Laurus Defendants". Signed by Judge Richard G. Andrews on 12/30/2022. Associated Cases: 1:19-md-02902-RGA, 1:22-cv-01348-RGA(nms) (Entered: 12/30/2022) (3) |
| Dec 30, 2022 | 9 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708. (Attachments: # 1 Consent Judgment)(nms) (Entered: 12/30/2022) (Main Document) (1) |
| Dec 30, 2022 | 9 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708. (Attachments: # 1 Consent Judgment)(nms) (Entered: 12/30/2022) (Consent Judgment) (3) |
| Dec 21, 2022 | 7 | PROPOSED Consent Judgment, by Merck Sharp & Dohme LLC. (Joyce, Alexandra) Modified on 12/21/2022 (nms). (Entered: 12/21/2022) (3) |
| Oct 12, 2022 | 1 | Complaint* (1) |
| Oct 12, 2022 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (lam) (Entered: 10/12/2022) (3) |
| Oct 12, 2022 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No Earlier than August 29th, 2022. Date of Expiration of Patent: November 24, 2026 (May 24, 2027 pediatric exclusivity expiration).Thirty Month Stay Deadline: 2/28/2025. (lam) (Entered: 10/12/2022) (2) |
| Oct 12, 2022 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708. (lam) (Entered: 10/12/2022) (1) |
| Oct 12, 2022 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck & Co., Inc. for Merck Sharp & Dohme LLC filed by Merck Sharp & Dohme LLC. (lam) (Entered: 10/12/2022) (2) |
| Oct 12, 2022 | 6 | Summons Issued as to Laurus Generics Inc. on 10/12/2022; Laurus Labs Limited on 10/12/2022. (Attachments: # 1 Summons Issued)(lam) (Entered: 10/12/2022) (Main Document) (2) |
| Oct 12, 2022 | 6 | Summons Issued as to Laurus Generics Inc. on 10/12/2022; Laurus Labs Limited on 10/12/2022. (Attachments: # 1 Summons Issued)(lam) (Entered: 10/12/2022) (Summons Issued) (2) |
